MetLife Investment Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.05M | Sell |
32,395
-19
| -0.1% | -$1.2K | 0.01% | 977 |
|
2025
Q1 | $1.72M | Sell |
32,414
-1,084
| -3% | -$57.4K | 0.01% | 1114 |
|
2024
Q4 | $1.88M | Buy |
33,498
+1,846
| +6% | +$103K | 0.01% | 1080 |
|
2024
Q3 | $1.66M | Hold |
31,652
| – | – | 0.01% | 1122 |
|
2024
Q2 | $1.3M | Buy |
31,652
+4,529
| +17% | +$186K | 0.01% | 1208 |
|
2024
Q1 | $1.18M | Hold |
27,123
| – | – | 0.01% | 1214 |
|
2023
Q4 | $1.25M | Hold |
27,123
| – | – | 0.01% | 1182 |
|
2023
Q3 | $622K | Hold |
27,123
| – | – | ﹤0.01% | 1491 |
|
2023
Q2 | $447K | Buy |
+27,123
| New | +$447K | ﹤0.01% | 1769 |
|
2022
Q2 | – | Sell |
-24,442
| Closed | -$282K | – | 2900 |
|
2022
Q1 | $282K | Buy |
24,442
+9,070
| +59% | +$104K | ﹤0.01% | 2130 |
|
2021
Q4 | $153K | Hold |
15,372
| – | – | ﹤0.01% | 2214 |
|
2021
Q3 | $201K | Hold |
15,372
| – | – | ﹤0.01% | 2099 |
|
2021
Q2 | $301K | Hold |
15,372
| – | – | ﹤0.01% | 1886 |
|
2021
Q1 | $327K | Hold |
15,372
| – | – | ﹤0.01% | 1763 |
|
2020
Q4 | $457K | Hold |
15,372
| – | – | ﹤0.01% | 1530 |
|
2020
Q3 | $333K | Hold |
15,372
| – | – | ﹤0.01% | 1579 |
|
2020
Q2 | $343K | Buy |
15,372
+1,907
| +14% | +$42.5K | ﹤0.01% | 1584 |
|
2020
Q1 | $205K | Hold |
13,465
| – | – | ﹤0.01% | 1682 |
|
2019
Q4 | $309K | Buy |
13,465
+2,209
| +20% | +$50.7K | ﹤0.01% | 1727 |
|
2019
Q3 | $243K | Hold |
11,256
| – | – | ﹤0.01% | 1836 |
|
2019
Q2 | $248K | Buy |
11,256
+5,064
| +82% | +$111K | ﹤0.01% | 1904 |
|
2019
Q1 | $170K | Hold |
6,192
| – | – | ﹤0.01% | 2060 |
|
2018
Q4 | $166K | Hold |
6,192
| – | – | ﹤0.01% | 2006 |
|
2018
Q3 | $181K | Buy |
+6,192
| New | +$181K | ﹤0.01% | 2143 |
|
2018
Q1 | – | Sell |
-9,862
| Closed | -$287K | – | 2213 |
|
2017
Q4 | $287K | Buy |
+9,862
| New | +$287K | ﹤0.01% | 1735 |
|